Pivotal Trials Will Address Diversity With New FDA Initiative ...Middle East

Expected sometime in 2025, details on plans for enrollment by race, ethnicity, age, and sex will be required for all pivotal and phase 3 trials, according to a new FDA initiative. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Pivotal Trials Will Address Diversity With New FDA Initiative )

Also on site :

• Love Island USA’s Cierra exits show after ‘racism’ scandal as partner Nic ‘wastes no time’ finding new connection
• ‘Rick and Morty’ Boss on How James Gunn and Zack Snyder Agreed to Parody Themselves and Their Dueling ‘Superman’ Takes (EXCLUSIVE)
• Morning Report — Texas braces for more flood danger after Hill Country tragedy